Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study
- PMID: 20404219
- DOI: 10.1161/HYPERTENSIONAHA.109.148999
Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study
Abstract
The beta-blocker atenolol is less effective than angiotensin-receptor blockers and calcium-channel blockers for reducing central blood pressure (BP). The trial was designed to determine whether the advantages of angiotensin-receptor blockers over atenolol remained significant when both were combined with the calcium-channel blocker amlodipine. A prospective, randomized, blinded endpoint (PROBE design) parallel group, multicenter trial including 393 patients with essential hypertension resistant to 4 weeks of 5 mg of amlodipine was set out. Central systolic BP, augmentation index (AIx; either rough or adjusted on heart rate), and carotid-to-femoral pulse wave velocity were measured with applanation tonometry (SphygmoCor) at inclusion and after 8 and 24 weeks of active treatment with an amlodipine-valsartan combination (5/80 mg and then 10/160 mg) or an amlodipine-atenolol combination (5/50 mg and then 10/100 mg). From baseline to week 24, central systolic BP decreased significantly more in the amlodipine-valsartan group (-13.70+/-1.15 mm Hg; P<0.0001) than in the amlodipine-atenolol group (-9.70+/-1.10 mm Hg; P<0.0001; difference: -4.00 mm Hg [95% CI: -7.10 to -0.90]; P=0.013), despite similar changes in brachial systolic BP. The difference in rough AIx reduction was -6.5% (95% CI: -8.3 to -4.7; P<0.0001) in favor of amlodipine-valsartan. AIx adjusted on heart rate was significantly reduced in favor of amlodipine-valsartan (-2.8% [95% CI: -4.92 to -0.68]; P<0.01). Heart rate decreased significantly more with amlodipine-atenolol (difference: -11 bpm [95% CI: -14 to -8 bpm]; P<0.001). Pulse wave velocity decreased by 0.95 m/s in both groups with no significant difference. Differences in central systolic BP and rough AIx remained significant after adjustment to the changes in heart rate. The amlodipine-valsartan combination decreased central (systolic and pulse) pressure and AIx more than the amlodipine-atenolol combination.
Comment in
-
Choosing an antihypertensive combination with a more efficient central blood pressure reduction.Expert Rev Cardiovasc Ther. 2010 Nov;8(11):1523-5. doi: 10.1586/erc.10.144. Expert Rev Cardiovasc Ther. 2010. PMID: 21090926
Similar articles
-
Destiffening effect of valsartan and atenolol: influence of heart rate and blood pressure.J Hypertens. 2014 Jan;32(1):108-14. doi: 10.1097/HJH.0000000000000014. J Hypertens. 2014. PMID: 24275838 Clinical Trial.
-
Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.Clin Ther. 2007 Feb;29(2):279-89. doi: 10.1016/j.clinthera.2007.02.003. Clin Ther. 2007. PMID: 17472820 Clinical Trial.
-
Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering.Hypertension. 2008 Jun;51(6):1617-23. doi: 10.1161/HYPERTENSIONAHA.108.111674. Epub 2008 Apr 21. Hypertension. 2008. PMID: 18426991 Clinical Trial.
-
Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.Am J Cardiovasc Drugs. 2009;9(5):309-30. doi: 10.2165/11201120-000000000-00000. Am J Cardiovasc Drugs. 2009. PMID: 19791840 Review.
-
Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.Adv Ther. 2008 Apr;25(4):300-20. doi: 10.1007/s12325-008-0042-x. Adv Ther. 2008. PMID: 18449492 Review.
Cited by
-
Effect of bisoprolol on central aortic systolic pressure in Chinese hypertensive patients after the initial dose and long-term treatment.Bosn J Basic Med Sci. 2022 Jun 1;22(3):427-434. doi: 10.17305/bjbms.2021.6483. Bosn J Basic Med Sci. 2022. PMID: 34716698 Free PMC article.
-
The Role of Central Blood Pressure Monitoring in the Management of Hypertension.Curr Cardiol Rep. 2018 Apr 19;20(6):41. doi: 10.1007/s11886-018-0991-x. Curr Cardiol Rep. 2018. PMID: 29675613 Review.
-
Arterial (Aortic) Stiffness in Patients with Resistant Hypertension: from Assessment to Treatment.Curr Hypertens Rep. 2017 Jan;19(1):2. doi: 10.1007/s11906-017-0704-7. Curr Hypertens Rep. 2017. PMID: 28091867 Review.
-
I Luso-Brazilian Positioning on Central Arterial Pressure.Arq Bras Cardiol. 2017 Feb;108(2):100-108. doi: 10.5935/abc.20170011. Epub 2017 Feb 13. Arq Bras Cardiol. 2017. PMID: 28327876 Free PMC article. No abstract available.
-
Central blood pressure: current evidence and clinical importance.Eur Heart J. 2014 Jul;35(26):1719-25. doi: 10.1093/eurheartj/eht565. Epub 2014 Jan 23. Eur Heart J. 2014. PMID: 24459197 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical